On November 16, Hims & Hers Health Inc. saw an Intraday Decline of 5.02% in Regular Trading, trading at $19.0399 per share with turnover of $38.1441 million.
The move followed continued pressure from weaker-than-expected third-quarter results, softer fourth-quarter and full-year revenue guidance, and an expanded FTC lawsuit adding five states as co-plaintiffs.
In the latest quarter, the company reported a loss of $0.14 per share versus expectations for a $0.06 profit, while revenue rose to $890.4 million but missed consensus near $893.1 million. Hims & Hers Health Inc. guided fourth-quarter revenue to $875 million-$895 million, below expectations of about $953.8 million, and projected full-year revenue of $3.13 billion-$3.15 billion versus consensus near $3.21 billion. The amended FTC complaint alleges improper sharing of sensitive health information and misleading billing and subscription-cancellation practices, adding further overhang to sentiment.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments